The content in this preview is based on the last saved version of your email - any changes made to your email that have not been saved will not be shown in this preview.
NCH Rooney Heart Institute Webinar Series
A New Era in Hypertrophic Cardiomyopathy
Treatment and Clinical Practice
Presented by: Viviana Navas, MD
🗓 Wednesday, September 9, 2026
🕘 5:30 PM – 6:10 PM (ET)
📍 Virtual – Join from Anywhere
Hypertrophic cardiomyopathy care is entering a new chapter. With the emergence of targeted disease-modifying therapies and evolving intervention strategies, clinicians have more options than ever to improve patient quality of life and long-term outcomes.
In this exclusive webinar, Viviana Navas, MD, of the NCH Rooney Heart Institute, home to one of the region’s most active Hypertrophic Cardiomyopathy (HCM) clinics on Florida's West Coast, will share real-world clinical insights, practical treatment strategies, and the latest evidence shaping the future of HCM care.
During this session, Dr. Navas breaks down how to:
Navigate Novel Therapies: Evaluate recent advances in pharmacologic care, including the practical integration of cardiac myosin inhibitors alongside standard medical management.
Compare Interventional Strategies: Weigh the indications, clinical benefits, safety limitations, and monitoring protocols for medical therapy versus septal reduction techniques.
Personalize Treatment Algorithms: Tailor patient-centered care plans based on LVOT obstruction severity, persistent symptoms, arrhythmic risk stratification, and disease trajectory.
Whether you are looking to optimize your medical titration protocols or refine referral timing for advanced interventions, this session delivers actionable guidance grounded in high-volume clinical experience.
Live Q&A Session: Bring your questions and engage directly with Dr. Navas as she discusses real-world cases and clinical challenges.
About Dr. Navas
Dr. Viviana Navas is the Section Head of Heart Failure and Director of the ACGME-Accredited Cardiology Fellowship Program at the NCH Rooney Heart Institute, where she leads the initiative to build a specialized heart failure program focused on early diagnosis and advancing clinical outcomes. A recognized leader in clinical cardiology, her areas of expertise include advanced heart failure, mechanical circulatory support, and heart transplantation.
Prior to joining NCH, Dr. Navas served as the Regional Director for Heart Failure at Cleveland Clinic Florida. During her tenure there, she founded and served as the medical director for the Heart Transplant and Mechanical Circulatory Support Program from 2014 to 2021, while also leading as the Cardiology Fellowship Program Director. Passionate about medical education and cardiac care innovation, Dr. Navas regularly shares her expertise as a speaker at national and international medical conferences.
